Filament Health Corp. FLHLF
0.00 USD 0.00 (+0.00%)
At closeApr 29, 2026, 4:00 PM EDT
0.0001 Day range 0.0001
0.0001 52-week range 0.0201
- YTD
- 0.00%
- 1 year
- -99.60%
News
newsfilecorp.com Red Light Holland Completes Acquisition of Filament Health, Creating a Global Leader in Psychedelic Drug Development, Commercialization and Distribution Establishes a vertically integrated platform spanning pharmaceutical-grade botanical drug development and global consumer distribution Adds Filament's extensive intellectual property portfolio,…
newsfilecorp.com Red Light Holland Announces Filament Health Obtains Final Order for Proposed Arrangement Toronto, Ontario--(Newsfile Corp. - April 29, 2026) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light" or the "Company") and Filament Health Corp. (OTC: FLHLF) ("Filament")…
newsfilecorp.com Red Light Holland Announces Filament Health Shareholder Approval of Acquisition Toronto, Ontario--(Newsfile Corp. - April 27, 2026) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light") and Filament Health Corp. (OTC: FLHLF) ("Filament") are pleased to…
newsfilecorp.com Red Light Holland Announces Filament Health Obtains Interim Order for Proposed Arrangement Toronto, Ontario--(Newsfile Corp. - March 23, 2026) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light" or the "Company") and Filament Health Corp. (OTC: FLHLF) ("Filament")…
accessnewswire.com Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, Initiates Preclinical Study of Coca for Appetite Suppression Whole leaf coca extract under evaluation is Magdalena's drug candidate for post-GLP-1 weight loss management SAN FRANCISCO, CA / ACCESS Newswire / March 16, 2026 / Jaguar Health, Inc. (NASDAQ:JAGX)…
newsfilecorp.com RETRANSMISSION: Red Light Holland Signs Definitive Agreement with Filament Health to Expand Its Platform for Natural Psychedelic Drug Development and Microdosing Innovation Expands Red Light's drug development platform with Filament's GMP manufacturing, Health Canada Dealer's Licence, Health Canada and FDA-authorized clinical programs, and 76 issued patents covering…
newsfilecorp.com Red Light Holland Signs Definitive Agreement with Filament Health to Expand Its Platform for Natural Psychedelic Drug Development and Microdosing Innovation Expands Red Light's drug development platform with Filament's GMP manufacturing, Health Canada Dealer's Licence, Health Canada and FDA-authorized clinical programs, and 76 issued patents covering…
accessnewswire.com Coca Access and Benefit Sharing Agreement Authorized by Peru's National Institute of Agrarian Innovation (INIA) Supports Research Efforts of Jaguar Health and Filament Health Joint Venture, Magdalena Biosciences, into Potential Mental Health and CNS Indications of Coca Magdalena is focused on developing novel, natural prescription medicines derived from plants for mental health indications SAN FRANCISCO, CA / ACCESS Newswire / July 8, 2025 / Jaguar Health, Inc.…
proactiveinvestors.com Filament Health unveils positive data from Phase 2 alcohol use disorder trial Filament Health Corp (NEO:FH, OTCQB:FLHLF) announced that its psilocybin drug candidate, PEX010, reduced heavy drinking days by more than 50% in a Phase 2 clinical trial targeting patients with…
accessnewswire.com Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, to Present February 10th at BIO CEO & Investor Conference Magdalena aiming to submit Investigational New Drug (IND) application in 2025 to the FDA for a next-generation psychoactive prescription drug candidate for potential mental health indications such as…
accesswire.com Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, to Present January 12 at the Annual Neuroscience Innovation Forum Magdalena aiming to submit Investigational New Drug (IND) application in early 2025 to the FDA for a next-generation psychoactive prescription drug candidate for potential mental health indications…
accesswire.com Jaguar Health Announces Import of Coca Leaf From Peru by Joint Venture Magdalena Biosciences for Research in Treating Mental Health Indications Magdalena to explore coca leaf's possible therapeutic benefit for treatment of potentially ADHD or other neuropsychiatric indications The import was conducted in collaboration with the government of…
accesswire.com Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, to Present October 16 at BIO Investor Forum Magdalena aiming to submit Investigational New Drug (IND) application in early 2025 to the FDA for a next-generation psychoactive prescription drug candidate for potential mental health indications…
accesswire.com Key Collaborator of Jaguar Health Joint Venture Magdalena Biosciences Receives Prestigious Alzheimer's Association Award Magdalena Biosciences, a joint venture formed by Jaguar and Filament Health, is focused on developing novel prescription psychoactive plant-based medicines for various mental health indications SAN…
proactiveinvestors.com Filament Health secures key approvals to advance botanical psilocybin in Q2 Filament Health Corp (NEO:FH, OTCQB:FLHLF) has announced its financial results for the second quarter, a pivotal quarter for the company as it was given the green light from both Health Canada and…
proactiveinvestors.com Filament Health expands intellectual property portfolio Filament Health Corp (NEO:FH, OTCQB:FLHLF) announced that it has expanded its intellectual property portfolio with the acceptance of 12 patents for processes relating to the development of botanical…
accesswire.com Elaine Elisabetsky, PhD, Member of Jaguar Health's Mental Health Entheogen Therapeutics Initiative, to Speak August 2nd About Plant-Based Medicines Used to Manage Schizophrenia at the University of Illinois Chicago College of Pharmacy Dr. Elisabetsky is also an advisor to Magdalena Biosciences , the joint venture formed by Jaguar and Filament Health focused on identifying the next generation of plant-based first-in-class agents…
proactiveinvestors.com Filament Health secures bridge financing deal Filament Health Corp (NEO:FH, OTCQB:FLHLF) has secured a bridge financing deal totaling C$1.0 million with Negev Capital Fund One and CEO Benjamin Lightburn. Negev Capital will exercise warrants to…
proactiveinvestors.com Filament Health expands substance abuse treatment studies in first quarter Filament Health Corp (NEO:FH, OTCQB:FLHLF) has hailed expansion of its substance abuse treatment to researchers across the world in first-quarter results. PEX010, Filament's botanical psilocybin drug…
proactiveinvestors.com Filament Health zeroes in on botanical psilocybin for substance use disorders Filament Health Corp (NEO:FH, OTCQB:FLHLF) CEO Benjamin Lightburn sees another exciting year ahead for the Vancouver-based drug developer after in 2023 it sharpened its focus to advancing its…